Terms: = Endocrine gland cancer AND MAF, MGC71685, 4094, ENSG00000178573 AND Treatment
11 results:
1. A multigene circulating biomarker to predict the lack of FOLFIRINOX response after a single cycle in patients with pancreatic ductal adenocarcinoma.
van Eijck CWF; de Koning W; van der Sijde F; Moskie M; Groot Koerkamp B; Homs MYV; van der Burg SH; van Eijck CHJ; Mustafa DAM
Eur J Cancer; 2023 Mar; 181():119-134. PubMed ID: 36652890
[TBL] [Abstract] [Full Text] [Related]
2. Genomic Landscape of Advanced Solid Tumors in Circulating Tumor DNA and Correlation With Tissue Sequencing: A Single Institution's Experience.
Gerratana L; Movarek M; Wehbe F; Katam N; Mahalingam D; Donahue J; Shah A; Chae YK; Mulcahy M; Tsarwhas D; Villaflor V; Kalyan A; Hussein M; Patel J; Chandra S; Platanias LC; Gradishar W; Cristofanilli M; Behdad A
JCO Precis Oncol; 2022 Jun; 6():e2100289. PubMed ID: 35772051
[TBL] [Abstract] [Full Text] [Related]
3. KRAS gene mutation quantification in the resection or venous margins of pancreatic ductal adenocarcinoma is not predictive of disease recurrence.
Amintas S; Fernandez B; Chauvet A; Chiche L; Laurent C; Belleannée G; Marty M; Buscail E; Dabernat S
Sci Rep; 2022 Feb; 12(1):2976. PubMed ID: 35194118
[TBL] [Abstract] [Full Text] [Related]
4. Targeted Transcriptome and
Lundy J; Gao H; Berry W; Masoumi-Moghoddam S; Jenkins BJ; Croagh D
Clin Cancer Res; 2021 Nov; 27(21):5900-5911. PubMed ID: 34400416
[TBL] [Abstract] [Full Text] [Related]
5. Prediction of new targets and mechanisms for quercetin in the treatment of pancreatic cancer, colon cancer, and rectal cancer.
Pang B; Xu X; Lu Y; Jin H; Yang R; Jiang C; Shao D; Liu Y; Shi J
Food Funct; 2019 Sep; 10(9):5339-5349. PubMed ID: 31393490
[TBL] [Abstract] [Full Text] [Related]
6. Circulating Nucleic Acids Are Associated With Outcomes of Patients With Pancreatic cancer.
Bernard V; Kim DU; San Lucas FA; Castillo J; Allenson K; Mulu FC; Stephens BM; Huang J; Semaan A; Guerrero PA; Kamyabi N; Zhao J; Hurd MW; Koay EJ; Taniguchi CM; Herman JM; Javle M; Wolff R; Katz M; Varadhachary G; Maitra A; Alvarez HA
Gastroenterology; 2019 Jan; 156(1):108-118.e4. PubMed ID: 30240661
[TBL] [Abstract] [Full Text] [Related]
7. PD-L1
Pollari M; Brück O; Pellinen T; Vähämurto P; Karjalainen-Lindsberg ML; Mannisto S; Kallioniemi O; Kellokumpu-Lehtinen PL; Mustjoki S; Leivonen SK; Leppä S
Haematologica; 2018 Nov; 103(11):1908-1914. PubMed ID: 30026337
[TBL] [Abstract] [Full Text] [Related]
8. Clinical significance of microscopic anaplastic focus in papillary thyroid carcinoma.
Choi JY; Hwang BH; Jung KC; Min HS; Koo do H; Youn YK; Lee KE
Surgery; 2013 Jul; 154(1):106-10. PubMed ID: 23809489
[TBL] [Abstract] [Full Text] [Related]
9. Towards the definition of the best management and prognostic factors of teratoma with malignant transformation: a single-institution case series and new proposal.
Necchi A; Colecchia M; Nicolai N; Piva L; Catanzaro M; Biasoni D; Torelli T; Stagni S; Paolini B; Milani A; Salvioni R
BJU Int; 2011 Apr; 107(7):1088-94. PubMed ID: 20868391
[TBL] [Abstract] [Full Text] [Related]
10. Pancreatic carcinogenesis: apoptosis and angiogenesis.
Onizuka S; Kawakami S; Taniguchi K; Fujioka H; Miyashita K
Pancreas; 2004 Apr; 28(3):317-9. PubMed ID: 15084979
[TBL] [Abstract] [Full Text] [Related]
11. Triple drug chemotherapy for advanced ovarian carcinoma: comparative study of two regimens.
Aroney RS; Levi JA; Dalley DN
Med J Aust; 1981 Jun; 1(12):633-5. PubMed ID: 7019638
[TBL] [Abstract] [Full Text] [Related]
